Mr. Paul Levesque reports

THERATECHNOLOGIES TO ANNOUNCE FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE

Theratechnologies Inc. will release financial results and provide a business update for its first quarter 2025 ended Feb. 28 on Wednesday, April 9, 2025, at 8:30 a.m. ET.

The call will be hosted by Paul Levesque, president and chief executive officer, who will be joined by other members of the management team, including Philippe Dubuc, senior vice-president and chief financial officer, Christian Marsolais, PhD, senior vice-president and chief medical officer, and John Leasure, global commercial officer. They will be available to answer questions from participants following prepared remarks.

Participants are encouraged to join the call at least 10 minutes in advance to secure access. Conference call dial-in and replay information can be found in the attached table.

An archived webcast will also be available on the company's investor relations website under past events.

About Theratechnologies Inc.

Theratechnologies is a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care.